PHP
SGEN

Parkman Healthcare Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Parkman Healthcare Partners’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,602
Closed -$4.35M – 117
2023
Q2 		$4.35M Sell
22,602
-50,498
-69% -$10M 0.75% 40
2023
Q1 		$14.8M Sell
73,100
-8,754
-11% -$1.4M 3.22% 6
2022
Q4 		$10.5M Buy
81,854
+9,457
+13% +$1.22M 2.8% 7
2022
Q3 		$9.91M Sell
72,397
-4,229
-6% -$689K 2.82% 9
2022
Q2 		$13.6M Sell
76,626
-9,470
-11% -$1.36M 4.99% 3
2022
Q1 		$12.4M Buy
86,096
+5,301
+7% +$717K 3.63% 4
2021
Q4 		$12.5M Buy
80,795
+8,119
+11% +$1.36M 2.76% 10
2021
Q3 		$12.3M Buy
72,676
+27,500
+61% +$4.28M 3.12% 8
2021
Q2 		$7.13M Buy
+45,176
New +$6.71M 1.56% 21
2020
Q3 		– Sell
-37,500
Closed -$6.37M – 96
2020
Q2 		$6.37M Buy
37,500
+2,390
+7% +$357K 1.8% 24
2020
Q1 		$4.05M Sell
35,110
-85,111
-71% -$9.42M 1.88% 19
2019
Q4 		$13.7M Buy
+120,221
New +$12.7M 3.97% 4

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parkman Healthcare Partners's SGEN Position: Q3 2023 in Review

Parkman Healthcare Partners sold out of Seagen Inc. Common Stock (SGEN) in Q3 2023, closing a stake of 22,602 shares — an estimated $4.35M sold.

Parkman Healthcare Partners first reported a position in SGEN in Q4 2019 and held it in 12 quarters. The position peaked at $14.8M in Q1 2023. 616 funds tracked by Wall St. Rank hold SGEN as of Q3 2023.

  • Parkman Healthcare Partners reported no remaining Seagen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 22,602 Seagen Inc. Common Stock shares in Q3 2023, an estimated $4.35M.
  • Parkman Healthcare Partners first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Parkman Healthcare Partners's Seagen Inc. Common Stock position peaked at $14.8M in Q1 2023.
  • 616 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2023.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.